Avidity Biosciences
235 hedge funds and large institutions have $3.71B invested in Avidity Biosciences in 2024 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 85 increasing their positions, 77 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
3% less funds holding
Funds holding: 242 → 235 (-7)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
35% less capital invested
Capital invested by funds: $5.75B → $3.71B (-$2.04B)
Holders
235
Holding in Top 10
8
Calls
$19.5M
Puts
$20.9M
Top Buyers
| 1 | +$62.7M | |
| 2 | +$31.3M | |
| 3 | +$18.2M | |
| 4 |
Morgan Stanley
New York
|
+$17.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$24.8M | |
| 3 | -$21.8M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$20.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$16M |